Integrated miRNAome-transcriptome analyses identify an immuno-hematopoietic subcluster in patients with long COVID - 05/10/26
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Graphical abstract |
Abstract |
Background |
Persistent symptoms following SARS-CoV-2 infection, termed post-COVID-19 condition or long COVID (LC), impose substantial psychological and socioeconomic burdens. However, microRNA (miRNA)-mRNA interactions underlying LC heterogeneity remain incompletely defined.
Objective |
We sought to determine whether integrative blood miRNA-mRNA profiling identifies molecular LC subclusters linked to clinical and immuno-hematopoietic features.
Methods |
We performed integrated miRNAome-transcriptome profiling of circulating blood RNA from individuals with LC and recovered control participants. Differential miRNA and mRNA expression was assessed using limma software, and hierarchical clustering was used to define LC subclusters. Validated miRNA-mRNA interaction networks were constructed using the miRNet tool. Clinical, functional, and biochemical parameters were compared between subclusters, and a random forest classifier was developed.
Results |
Clustering identified an immuno-hematopoietic LC subcluster, LC1, characterized by extensive miRNA-mRNA dysregulation; enrichment of erythropoietic, platelet, and immune pathways; and biochemical alterations including lower plasma sodium and elevated fibrin D-dimer and thrombin time. Compared with subcluster LC2, LC1 showed persistently greater symptom burden, functional impairment, reduced quality of life, lower resilience, and higher anxiety/depressive symptoms. Potential confounding by age, sex, comorbidities, and selected medication use was evaluated. Network and coexpression analyses identified regulatory nodes enriched for viral infection and natural killer cell activation pathways. A random forest classifier incorporating 9 miRNAs and LRRFIP2 achieved an area under the receiver operating characteristic curve of 0.91 for LC1, distinguishing LC1 from LC2 and recovered control participants.
Conclusions |
LC comprises biologically and clinically distinct subclusters shaped by coordinated miRNA-mRNA remodeling. The immuno-hematopoietic LC1 subcluster supports biomarker-based stratification of patients with persistent physiologic and clinical impairment.
Le texte complet de cet article est disponible en PDF.Key words : miRNA, mRNA, multi-omics, long COVID, SARS-CoV-2
Abbreviations used : COVID-19, DEG, DEmiRNA, GO, HUS, KEGG, LC, MAPK, miRNA, NK, PCA, PPI, ROC
Plan
Vol 158 - N° 4
P. 1133 - octobre 2026 Retour au numéro
Article précédent
- Common γ-chain cytokines induce an epigenomically plastic precursor-like KIT+ ILC2 state linked to immune disease susceptibility
- Simone E.M. Olsthoorn, Anne Onrust-Van Schoonhoven, Marjolein J.W. de Bruijn, Jochem Weekers, Menno van Nimwegen, Gregory van Beek, Willem de Koning, Lianne Trap, Esmee K. van der Ploeg, Geert H. van Weelden, Mathijs A. Sanders, Laura Surace, James P. Di Santo, Rudi W. Hendriks, Ralph Stadhouders
- Human mast cells produce DHA-derived bioactive mediators: Resolvins D1, D2, and D4
- Tresa George, Robert Nshimiyimana, David Mankuta, Charles N. Serhan, Francesca Levi-Schaffer
Bienvenue sur EM-consulte, la référence des professionnels de santé.